0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Butorphanol - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-12L8315
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Butorphanol Market Insights Forecast to 2028
BUY CHAPTERS

Butorphanol - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-12L8315
Report
November 2024
Pages:132
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Butorphanol - Market Size

The global market for Butorphanol was estimated to be worth US$ 1712 million in 2023 and is forecast to a readjusted size of US$ 2469.2 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030

Butorphanol - Market

Butorphanol - Market

Butorphanol is a morphinan-type synthetic agonist–antagonist opioid analgesic developed by Bristol-Myers. Butorphanol is available as the tartrate salt in injectable, tablet, and intranasal spray formulations. The tablet form is only used in dogs, cats and horses due to low bioavailability in humans.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Butorphanol, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Butorphanol by region & country, by Type, and by Application.
The Butorphanol market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Butorphanol.
Market Segmentation

Scope of Butorphanol - Market Report

Report Metric Details
Report Name Butorphanol - Market
Forecasted market size in 2030 US$ 2469.2 million
CAGR 5.4%
Forecasted years 2024 - 2030
Segment by Type:
  • Spray
  • Injection
  • Tablet
Segment by Application
  • Human
  • Veterinary
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Hikma Pharmaceuticals, Athanas Enterprise Private Limited, Pfizer, Apothecon Pharmaceuticals, Mylan, Novex Pharma, Bristol Myers Squibb, Sanochemia Pharmazeutika, Selectavet, Richter Pharma Ag, Troy Laboratories Nz, Animedica, Boehringer Ingelheim Santé Animale, Ausrichter, Zoetis, Dechra Pharmaceuticals, Faunapharma, Merck KGaA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Butorphanol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Butorphanol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Butorphanol in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Butorphanol - Market size in 2030?

Ans: The Butorphanol - Market size in 2030 will be US$ 2469.2 million.

Who are the main players in the Butorphanol - Market report?

Ans: The main players in the Butorphanol - Market are Hikma Pharmaceuticals, Athanas Enterprise Private Limited, Pfizer, Apothecon Pharmaceuticals, Mylan, Novex Pharma, Bristol Myers Squibb, Sanochemia Pharmazeutika, Selectavet, Richter Pharma Ag, Troy Laboratories Nz, Animedica, Boehringer Ingelheim Santé Animale, Ausrichter, Zoetis, Dechra Pharmaceuticals, Faunapharma, Merck KGaA

What are the Application segmentation covered in the Butorphanol - Market report?

Ans: The Applications covered in the Butorphanol - Market report are Human, Veterinary

What are the Type segmentation covered in the Butorphanol - Market report?

Ans: The Types covered in the Butorphanol - Market report are Spray, Injection, Tablet

1 Market Overview
1.1 Butorphanol Product Introduction
1.2 Global Butorphanol Market Size Forecast
1.2.1 Global Butorphanol Sales Value (2019-2030)
1.2.2 Global Butorphanol Sales Volume (2019-2030)
1.2.3 Global Butorphanol Sales Price (2019-2030)
1.3 Butorphanol Market Trends & Drivers
1.3.1 Butorphanol Industry Trends
1.3.2 Butorphanol Market Drivers & Opportunity
1.3.3 Butorphanol Market Challenges
1.3.4 Butorphanol Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Butorphanol Players Revenue Ranking (2023)
2.2 Global Butorphanol Revenue by Company (2019-2024)
2.3 Global Butorphanol Players Sales Volume Ranking (2023)
2.4 Global Butorphanol Sales Volume by Company Players (2019-2024)
2.5 Global Butorphanol Average Price by Company (2019-2024)
2.6 Key Manufacturers Butorphanol Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Butorphanol Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Butorphanol
2.9 Butorphanol Market Competitive Analysis
2.9.1 Butorphanol Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Butorphanol Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Butorphanol as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Spray
3.1.2 Injection
3.1.3 Tablet
3.2 Global Butorphanol Sales Value by Type
3.2.1 Global Butorphanol Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Butorphanol Sales Value, by Type (2019-2030)
3.2.3 Global Butorphanol Sales Value, by Type (%) (2019-2030)
3.3 Global Butorphanol Sales Volume by Type
3.3.1 Global Butorphanol Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Butorphanol Sales Volume, by Type (2019-2030)
3.3.3 Global Butorphanol Sales Volume, by Type (%) (2019-2030)
3.4 Global Butorphanol Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Human
4.1.2 Veterinary
4.2 Global Butorphanol Sales Value by Application
4.2.1 Global Butorphanol Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Butorphanol Sales Value, by Application (2019-2030)
4.2.3 Global Butorphanol Sales Value, by Application (%) (2019-2030)
4.3 Global Butorphanol Sales Volume by Application
4.3.1 Global Butorphanol Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Butorphanol Sales Volume, by Application (2019-2030)
4.3.3 Global Butorphanol Sales Volume, by Application (%) (2019-2030)
4.4 Global Butorphanol Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Butorphanol Sales Value by Region
5.1.1 Global Butorphanol Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Butorphanol Sales Value by Region (2019-2024)
5.1.3 Global Butorphanol Sales Value by Region (2025-2030)
5.1.4 Global Butorphanol Sales Value by Region (%), (2019-2030)
5.2 Global Butorphanol Sales Volume by Region
5.2.1 Global Butorphanol Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Butorphanol Sales Volume by Region (2019-2024)
5.2.3 Global Butorphanol Sales Volume by Region (2025-2030)
5.2.4 Global Butorphanol Sales Volume by Region (%), (2019-2030)
5.3 Global Butorphanol Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Butorphanol Sales Value, 2019-2030
5.4.2 North America Butorphanol Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Butorphanol Sales Value, 2019-2030
5.5.2 Europe Butorphanol Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Butorphanol Sales Value, 2019-2030
5.6.2 Asia Pacific Butorphanol Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Butorphanol Sales Value, 2019-2030
5.7.2 South America Butorphanol Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Butorphanol Sales Value, 2019-2030
5.8.2 Middle East & Africa Butorphanol Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Butorphanol Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Butorphanol Sales Value
6.2.1 Key Countries/Regions Butorphanol Sales Value, 2019-2030
6.2.2 Key Countries/Regions Butorphanol Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Butorphanol Sales Value, 2019-2030
6.3.2 United States Butorphanol Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Butorphanol Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Butorphanol Sales Value, 2019-2030
6.4.2 Europe Butorphanol Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Butorphanol Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Butorphanol Sales Value, 2019-2030
6.5.2 China Butorphanol Sales Value by Type (%), 2023 VS 2030
6.5.3 China Butorphanol Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Butorphanol Sales Value, 2019-2030
6.6.2 Japan Butorphanol Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Butorphanol Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Butorphanol Sales Value, 2019-2030
6.7.2 South Korea Butorphanol Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Butorphanol Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Butorphanol Sales Value, 2019-2030
6.8.2 Southeast Asia Butorphanol Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Butorphanol Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Butorphanol Sales Value, 2019-2030
6.9.2 India Butorphanol Sales Value by Type (%), 2023 VS 2030
6.9.3 India Butorphanol Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Hikma Pharmaceuticals
7.1.1 Hikma Pharmaceuticals Company Information
7.1.2 Hikma Pharmaceuticals Introduction and Business Overview
7.1.3 Hikma Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Hikma Pharmaceuticals Butorphanol Product Offerings
7.1.5 Hikma Pharmaceuticals Recent Development
7.2 Athanas Enterprise Private Limited
7.2.1 Athanas Enterprise Private Limited Company Information
7.2.2 Athanas Enterprise Private Limited Introduction and Business Overview
7.2.3 Athanas Enterprise Private Limited Butorphanol Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Athanas Enterprise Private Limited Butorphanol Product Offerings
7.2.5 Athanas Enterprise Private Limited Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Information
7.3.2 Pfizer Introduction and Business Overview
7.3.3 Pfizer Butorphanol Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Pfizer Butorphanol Product Offerings
7.3.5 Pfizer Recent Development
7.4 Apothecon Pharmaceuticals
7.4.1 Apothecon Pharmaceuticals Company Information
7.4.2 Apothecon Pharmaceuticals Introduction and Business Overview
7.4.3 Apothecon Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Apothecon Pharmaceuticals Butorphanol Product Offerings
7.4.5 Apothecon Pharmaceuticals Recent Development
7.5 Mylan
7.5.1 Mylan Company Information
7.5.2 Mylan Introduction and Business Overview
7.5.3 Mylan Butorphanol Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Mylan Butorphanol Product Offerings
7.5.5 Mylan Recent Development
7.6 Novex Pharma
7.6.1 Novex Pharma Company Information
7.6.2 Novex Pharma Introduction and Business Overview
7.6.3 Novex Pharma Butorphanol Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Novex Pharma Butorphanol Product Offerings
7.6.5 Novex Pharma Recent Development
7.7 Bristol Myers Squibb
7.7.1 Bristol Myers Squibb Company Information
7.7.2 Bristol Myers Squibb Introduction and Business Overview
7.7.3 Bristol Myers Squibb Butorphanol Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Bristol Myers Squibb Butorphanol Product Offerings
7.7.5 Bristol Myers Squibb Recent Development
7.8 Sanochemia Pharmazeutika
7.8.1 Sanochemia Pharmazeutika Company Information
7.8.2 Sanochemia Pharmazeutika Introduction and Business Overview
7.8.3 Sanochemia Pharmazeutika Butorphanol Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Sanochemia Pharmazeutika Butorphanol Product Offerings
7.8.5 Sanochemia Pharmazeutika Recent Development
7.9 Selectavet
7.9.1 Selectavet Company Information
7.9.2 Selectavet Introduction and Business Overview
7.9.3 Selectavet Butorphanol Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Selectavet Butorphanol Product Offerings
7.9.5 Selectavet Recent Development
7.10 Richter Pharma Ag
7.10.1 Richter Pharma Ag Company Information
7.10.2 Richter Pharma Ag Introduction and Business Overview
7.10.3 Richter Pharma Ag Butorphanol Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Richter Pharma Ag Butorphanol Product Offerings
7.10.5 Richter Pharma Ag Recent Development
7.11 Troy Laboratories Nz
7.11.1 Troy Laboratories Nz Company Information
7.11.2 Troy Laboratories Nz Introduction and Business Overview
7.11.3 Troy Laboratories Nz Butorphanol Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Troy Laboratories Nz Butorphanol Product Offerings
7.11.5 Troy Laboratories Nz Recent Development
7.12 Animedica
7.12.1 Animedica Company Information
7.12.2 Animedica Introduction and Business Overview
7.12.3 Animedica Butorphanol Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Animedica Butorphanol Product Offerings
7.12.5 Animedica Recent Development
7.13 Boehringer Ingelheim Santé Animale
7.13.1 Boehringer Ingelheim Santé Animale Company Information
7.13.2 Boehringer Ingelheim Santé Animale Introduction and Business Overview
7.13.3 Boehringer Ingelheim Santé Animale Butorphanol Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Boehringer Ingelheim Santé Animale Butorphanol Product Offerings
7.13.5 Boehringer Ingelheim Santé Animale Recent Development
7.14 Ausrichter
7.14.1 Ausrichter Company Information
7.14.2 Ausrichter Introduction and Business Overview
7.14.3 Ausrichter Butorphanol Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Ausrichter Butorphanol Product Offerings
7.14.5 Ausrichter Recent Development
7.15 Zoetis
7.15.1 Zoetis Company Information
7.15.2 Zoetis Introduction and Business Overview
7.15.3 Zoetis Butorphanol Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Zoetis Butorphanol Product Offerings
7.15.5 Zoetis Recent Development
7.16 Dechra Pharmaceuticals
7.16.1 Dechra Pharmaceuticals Company Information
7.16.2 Dechra Pharmaceuticals Introduction and Business Overview
7.16.3 Dechra Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Dechra Pharmaceuticals Butorphanol Product Offerings
7.16.5 Dechra Pharmaceuticals Recent Development
7.17 Faunapharma
7.17.1 Faunapharma Company Information
7.17.2 Faunapharma Introduction and Business Overview
7.17.3 Faunapharma Butorphanol Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Faunapharma Butorphanol Product Offerings
7.17.5 Faunapharma Recent Development
7.18 Merck KGaA
7.18.1 Merck KGaA Company Information
7.18.2 Merck KGaA Introduction and Business Overview
7.18.3 Merck KGaA Butorphanol Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Merck KGaA Butorphanol Product Offerings
7.18.5 Merck KGaA Recent Development
8 Industry Chain Analysis
8.1 Butorphanol Industrial Chain
8.2 Butorphanol Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Butorphanol Sales Model
8.5.2 Sales Channel
8.5.3 Butorphanol Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Butorphanol Market Trends
    Table 2. Butorphanol Market Drivers & Opportunity
    Table 3. Butorphanol Market Challenges
    Table 4. Butorphanol Market Restraints
    Table 5. Global Butorphanol Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Butorphanol Revenue Market Share by Company (2019-2024)
    Table 7. Global Butorphanol Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Butorphanol Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Butorphanol Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Butorphanol Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Butorphanol Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Butorphanol
    Table 13. Global Butorphanol Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Butorphanol as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Butorphanol Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Butorphanol Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Butorphanol Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Butorphanol Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Butorphanol Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Butorphanol Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Butorphanol Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Butorphanol Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Butorphanol Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Butorphanol Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Butorphanol Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Butorphanol Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Butorphanol Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Butorphanol Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Butorphanol Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Butorphanol Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Butorphanol Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Butorphanol Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Butorphanol Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Butorphanol Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Butorphanol Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Butorphanol Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Butorphanol Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Butorphanol Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Butorphanol Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Butorphanol Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Butorphanol Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Butorphanol Sales Value by Region (2019-2024) & (%)
    Table 44. Global Butorphanol Sales Value by Region (2025-2030) & (%)
    Table 45. Global Butorphanol Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Butorphanol Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Butorphanol Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Butorphanol Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Butorphanol Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Butorphanol Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Butorphanol Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Butorphanol Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Butorphanol Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Butorphanol Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Butorphanol Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Butorphanol Sales Volume, (2025-2030) & (K Units)
    Table 57. Hikma Pharmaceuticals Company Information
    Table 58. Hikma Pharmaceuticals Introduction and Business Overview
    Table 59. Hikma Pharmaceuticals Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Hikma Pharmaceuticals Butorphanol Product Offerings
    Table 61. Hikma Pharmaceuticals Recent Development
    Table 62. Athanas Enterprise Private Limited Company Information
    Table 63. Athanas Enterprise Private Limited Introduction and Business Overview
    Table 64. Athanas Enterprise Private Limited Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Athanas Enterprise Private Limited Butorphanol Product Offerings
    Table 66. Athanas Enterprise Private Limited Recent Development
    Table 67. Pfizer Company Information
    Table 68. Pfizer Introduction and Business Overview
    Table 69. Pfizer Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Pfizer Butorphanol Product Offerings
    Table 71. Pfizer Recent Development
    Table 72. Apothecon Pharmaceuticals Company Information
    Table 73. Apothecon Pharmaceuticals Introduction and Business Overview
    Table 74. Apothecon Pharmaceuticals Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Apothecon Pharmaceuticals Butorphanol Product Offerings
    Table 76. Apothecon Pharmaceuticals Recent Development
    Table 77. Mylan Company Information
    Table 78. Mylan Introduction and Business Overview
    Table 79. Mylan Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Mylan Butorphanol Product Offerings
    Table 81. Mylan Recent Development
    Table 82. Novex Pharma Company Information
    Table 83. Novex Pharma Introduction and Business Overview
    Table 84. Novex Pharma Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Novex Pharma Butorphanol Product Offerings
    Table 86. Novex Pharma Recent Development
    Table 87. Bristol Myers Squibb Company Information
    Table 88. Bristol Myers Squibb Introduction and Business Overview
    Table 89. Bristol Myers Squibb Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Bristol Myers Squibb Butorphanol Product Offerings
    Table 91. Bristol Myers Squibb Recent Development
    Table 92. Sanochemia Pharmazeutika Company Information
    Table 93. Sanochemia Pharmazeutika Introduction and Business Overview
    Table 94. Sanochemia Pharmazeutika Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Sanochemia Pharmazeutika Butorphanol Product Offerings
    Table 96. Sanochemia Pharmazeutika Recent Development
    Table 97. Selectavet Company Information
    Table 98. Selectavet Introduction and Business Overview
    Table 99. Selectavet Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Selectavet Butorphanol Product Offerings
    Table 101. Selectavet Recent Development
    Table 102. Richter Pharma Ag Company Information
    Table 103. Richter Pharma Ag Introduction and Business Overview
    Table 104. Richter Pharma Ag Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Richter Pharma Ag Butorphanol Product Offerings
    Table 106. Richter Pharma Ag Recent Development
    Table 107. Troy Laboratories Nz Company Information
    Table 108. Troy Laboratories Nz Introduction and Business Overview
    Table 109. Troy Laboratories Nz Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Troy Laboratories Nz Butorphanol Product Offerings
    Table 111. Troy Laboratories Nz Recent Development
    Table 112. Animedica Company Information
    Table 113. Animedica Introduction and Business Overview
    Table 114. Animedica Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Animedica Butorphanol Product Offerings
    Table 116. Animedica Recent Development
    Table 117. Boehringer Ingelheim Santé Animale Company Information
    Table 118. Boehringer Ingelheim Santé Animale Introduction and Business Overview
    Table 119. Boehringer Ingelheim Santé Animale Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Boehringer Ingelheim Santé Animale Butorphanol Product Offerings
    Table 121. Boehringer Ingelheim Santé Animale Recent Development
    Table 122. Ausrichter Company Information
    Table 123. Ausrichter Introduction and Business Overview
    Table 124. Ausrichter Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Ausrichter Butorphanol Product Offerings
    Table 126. Ausrichter Recent Development
    Table 127. Zoetis Company Information
    Table 128. Zoetis Introduction and Business Overview
    Table 129. Zoetis Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Zoetis Butorphanol Product Offerings
    Table 131. Zoetis Recent Development
    Table 132. Dechra Pharmaceuticals Company Information
    Table 133. Dechra Pharmaceuticals Introduction and Business Overview
    Table 134. Dechra Pharmaceuticals Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Dechra Pharmaceuticals Butorphanol Product Offerings
    Table 136. Dechra Pharmaceuticals Recent Development
    Table 137. Faunapharma Company Information
    Table 138. Faunapharma Introduction and Business Overview
    Table 139. Faunapharma Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Faunapharma Butorphanol Product Offerings
    Table 141. Faunapharma Recent Development
    Table 142. Merck KGaA Company Information
    Table 143. Merck KGaA Introduction and Business Overview
    Table 144. Merck KGaA Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Merck KGaA Butorphanol Product Offerings
    Table 146. Merck KGaA Recent Development
    Table 147. Key Raw Materials Lists
    Table 148. Raw Materials Key Suppliers Lists
    Table 149. Butorphanol Downstream Customers
    Table 150. Butorphanol Distributors List
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Butorphanol Product Picture
    Figure 2. Global Butorphanol Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Butorphanol Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Butorphanol Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Butorphanol Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Butorphanol Report Years Considered
    Figure 7. Global Butorphanol Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Butorphanol Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Butorphanol Revenue in 2023
    Figure 10. Butorphanol Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Spray Picture
    Figure 12. Injection Picture
    Figure 13. Tablet Picture
    Figure 14. Global Butorphanol Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Butorphanol Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Butorphanol Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Butorphanol Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Butorphanol Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Human
    Figure 20. Product Picture of Veterinary
    Figure 21. Global Butorphanol Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Butorphanol Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Butorphanol Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Butorphanol Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Butorphanol Price by Application (2019-2030) & (US$/Unit)
    Figure 26. North America Butorphanol Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Butorphanol Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Butorphanol Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Butorphanol Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Butorphanol Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Butorphanol Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Butorphanol Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Butorphanol Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Butorphanol Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Butorphanol Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Butorphanol Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Butorphanol Sales Volume (%), (2019-2030)
    Figure 38. United States Butorphanol Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Butorphanol Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Butorphanol Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Butorphanol Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Butorphanol Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Butorphanol Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Butorphanol Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Butorphanol Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Butorphanol Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Butorphanol Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Butorphanol Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Butorphanol Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Butorphanol Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Butorphanol Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Butorphanol Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Butorphanol Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Butorphanol Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Butorphanol Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Butorphanol Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Butorphanol Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Butorphanol Sales Value by Application (%), 2023 VS 2030
    Figure 59. Butorphanol Industrial Chain
    Figure 60. Butorphanol Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS